← Leaderboards
William J Buchser
Cell Microsystems, Inc.
$1,015,274
Attributed
$1,763,058
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $530.2K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,763,058 · 3
By mechanism
R01$1,338,069 · 1
R41$267,489 · 1
R03$157,500 · 1
Top collaborators
- Patricia I Dickson5 shared
Others in their field
Other Emerging Leaders on “Experimental Study”
- John Hobbs · Suny At Stony Brook$42,194,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Christopher Bee · Suny At Stony Brook$41,239,084
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,024,342
- John Damon Chodera · Sloan-Kettering Inst Can Research$18,835,102
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
Research focus
Experimental StudyLaboratoriesGenesImagePhenotypeCellsDiscriminationDisorder RiskIn VitroGenetic TestingBirthDiagnostic AccuracyClassificationIduronate-2-SulfataseGenetic VariantCell LineBiochemicalEnzymesAttenuatedA549DiagnosisBenignDiagnosticGlycosaminoglycans
Grant awards (6)
Cellular Phenotypes of Genetic Variants in Mucopolysaccharidosis$450,047
R01 · FY2025 · NS
Cellular Phenotypes of Genetic Variants in Mucopolysaccharidosis$436,544
R01 · FY2024 · NS
Cellular Phenotypes of Genetic Variants in Mucopolysaccharidosis$451,478
R01 · FY2023 · NS
Cellular phenotype of mucopolysaccharidosis II for studies of genomic variants$78,750
R03 · FY2023 · NS
Cellular phenotype of mucopolysaccharidosis II for studies of genomic variants$78,750
R03 · FY2022 · NS
Automated CRISPR Screening Using the CellRaft Technology$267,489
R41 · FY2019 · GM · contact PI